Ethiopia vs Saudi Arabia: Access to anti-retroviral drugs, male
Ethiopia
93.0%
in 2024
Saudi Arabia
93.0%
in 2024
Ethiopia rank
7th
Saudi Arabia rank
7th
Access to anti-retroviral drugs, male over time
- Ethiopia
- Saudi Arabia
How they compare
Ethiopia currently reports 93.0% against 93.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Saudi Arabia ahead.
Ethiopia ranks 7th and Saudi Arabia ranks 7th of 141 countries.
Across the 3 decades both report, Ethiopia averaged higher in 1 and Saudi Arabia in 2.
Head to head by decade
| Decade | Ethiopia | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.6% | 27.0% | 18.4% | Saudi Arabia |
| 2010s | 61.8% | 56.4% | 5.4% | Ethiopia |
| 2020s | 87.4% | 91.2% | 3.8% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Ethiopia or Saudi Arabia?
- Ethiopia, at 93.0% against 93.0% in Saudi Arabia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Ethiopia and Saudi Arabia?
- 0.0%, with Ethiopia ahead.
- How many years of comparable data are there for Ethiopia and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do Ethiopia and Saudi Arabia rank globally for access to anti-retroviral drugs, male?
- Ethiopia ranks 7th and Saudi Arabia ranks 7th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.